Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Milind Patel

Pain Medicine Evesham, NJ Medical Doctor

NPI 1063831584 CMS profile 7218321

751 Route 73 N Ste 10, Evesham, NJ 08053

Open in the dashboard

General payments

$3,191

51 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Milind Patel of Evesham, NJ is reported in the CMS Open Payments database as having received $3,191 across 51 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 62nd percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $398 13
2024 General $1,596 19
2023 General $166 4
2022 General $438 8
2020 General $138 1
2019 General $454 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Milind Patel
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Milind Patel were reported at $398. Among 1,144 Pain Medicine profiles paid that year, the median was $402 and the middle half received between $130 and $1,173.

Show as a table
Year Milind Patel Pain Medicine median Middle half National median
2019 $454 $409 $115–$1,311 $163
2020 $138 $214 $66–$666 $114
2021 $0 $299 $84–$899 $132
2022 $438 $335 $103–$1,149 $149
2023 $166 $376 $114–$1,228 $160
2024 $1,596 $387 $115–$1,173 $164
2025 $398 $402 $130–$1,173 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $1,244 15 payments
  2. Stryker Corporation $336 3 payments
  3. Abbott Laboratories $320 4 payments
  4. Nevro Corp. $258 5 payments
  5. Medtronic USA, Inc. $151 3 payments
  6. Vertos Medical, Inc. $148 2 payments
  7. Electronic Waveform Lab, Inc. $138 1 payment
  8. Verona Pharma, Inc. $125 1 payment
  9. Boston Scientific Corporation $94 3 payments
  10. Spinal Elements, Inc. $86 1 payment
  11. Other $291 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,191 51 payments
Products named General payments · program years 2019–2025
  1. INTELLIS ADAPTIVESTIM $814 10 payments
  2. VANTA ADAPTIVESTIM $397 3 payments
  3. EVEREST SPINAL SYSTEM $283 2 payments
  4. Senza $178 4 payments
  5. Medical Devices $173 2 payments
  6. INTELLIS $151 3 payments
  7. mild Device Kit $148 2 payments
  8. Ohtuvayre $125 1 payment
  9. Proclaim Family of SCS IPGs $111 1 payment
  10. Penta SCS Leads $106 1 payment
  11. Other $603 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$11,184

Medicare's payments for the services billed

Medicare patients

39

Average age 75

Services billed

107

23 women, 16 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 41%
Ischemic heart disease 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BELBUCA
  • Collegium Pharmaceutical, Inc. $16
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

51 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record